BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dittmar Y, Schüle S, Koch A, Rauchfuss F, Scheuerlein H, Settmacher U. Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer—a European single-centre experience. Langenbecks Arch Surg 2015;400:27-35. [DOI: 10.1007/s00423-014-1226-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Huang QX, Ma J, Wang YS. Significance of preoperative ischemia- modified albumin in operable and advanced gastric cancer. Cancer Biomark 2018;22:477-85. [PMID: 29843211 DOI: 10.3233/CBM-171090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ji MY, Yuan L, Jiang XD, Zeng Z, Zhan N, Huang PX, Lu C, Dong WG. Nuclear shape, architecture and orientation features from H&E images are able to predict recurrence in node-negative gastric adenocarcinoma. J Transl Med 2019;17:92. [PMID: 30885234 DOI: 10.1186/s12967-019-1839-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Zhou Y, Yu F, Wu L, Ye F, Zhang L, Li Y. Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors. Med Sci Monit 2015;21:1911-9. [PMID: 26134762 DOI: 10.12659/MSM.893856] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
4 Qu J, Qu X, Li Z, Zhang J, Teng Y, Jin B, Zhao M, Yu P, Wang Z, Liu Y. Role of patient-, tumor- and systemic inflammatory response-related factors in predicting survival of patients with node-negative gastric cancer. Tumour Biol. 2017;39:1010428317698374. [PMID: 28618960 DOI: 10.1177/1010428317698374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Huang B, Rouvelas I, Nilsson M. Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery. Annals of Gastroent Surgery. [DOI: 10.1002/ags3.12565] [Reference Citation Analysis]
6 Eo WK, Chang HJ, Suh J, Ahn J, Shin J, Hur JY, Kim GY, Lee S, Park S, Lee S. The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer. Nutr Cancer. 2015;67:1260-1267. [PMID: 26583916 DOI: 10.1080/01635581.2015.1082112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
7 Feng R, Sah BK, Li J, Lu S, Yuan F, Jin X, Yan M, Liu B, Li C, Zhu Z. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer. Cancer Biomark 2018;23:437-45. [PMID: 30248047 DOI: 10.3233/CBM-181526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Eo W, Kwon J, An S, Lee S, Kim S, Nam D, Han GY, Choi SI, Chung HY. Clinical Significance of Paraspinal Muscle Parameters as a prognostic factor for survival in Gastric Cancer Patients who underwent Curative Surgical Resection. J Cancer 2020;11:5792-801. [PMID: 32913472 DOI: 10.7150/jca.46637] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhang L, Chen H, Wang M, Song X, Ding F, Zhu J, Li X. Effects of glabridin combined with 5-fluorouracil on the proliferation and apoptosis of gastric cancer cells. Oncol Lett 2018;15:7037-45. [PMID: 29725429 DOI: 10.3892/ol.2018.8260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Zhao J, Du F, Zhang Y, Kan J, Dong L, Shen G, Zheng F, Chen H, Zhao J, Ji F, Luo Y, Ma F, Wang Z, Xu B. Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China. Medicine (Baltimore) 2016;95:e4420. [PMID: 27495062 DOI: 10.1097/MD.0000000000004420] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 An S, Eo W, Kim YJ. Muscle-Related Parameters as Determinants of Survival in Patients with Stage I-III Gastric Cancer Undergoing Gastrectomy. J Cancer 2021;12:5664-73. [PMID: 34405026 DOI: 10.7150/jca.61199] [Reference Citation Analysis]
12 Du XF, Zhang LL, Zhang DZ, Yang L, Fan YY, Dong SP. Clinical significance of serum total oxidant/antioxidant status in patients with operable and advanced gastric cancer. Onco Targets Ther 2018;11:6767-75. [PMID: 30349309 DOI: 10.2147/OTT.S153946] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lu M, Yang Z, Feng Q, Yu M, Zhang Y, Mao C, Shen L, Tang J. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients. Medicine (Baltimore) 2016;95:e4052. [PMID: 27399088 DOI: 10.1097/MD.0000000000004052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]